OBJECTIVE: Although recent studies link altered cellular redox state to protein dysfunction in various disease-states, such associations are least studied in clinical diabetes. Therefore, this study assessed the levels of reduced glutathione (GSH) and Na(+)/K(+) ATPase activities in type 2 diabetic patients with and without microangiopathy. METHODS: The study group comprised of a total of 160 subjects, which included non-diabetic healthy controls (n = 40) and type 2 diabetic patients without (n = 60) and with microangiopathy (n = 60), defined as presence of retinopathy with or without nephropathy. Erythrocyte Na(+)/K(+) ATPase activity and GSH levels were estimated spectrophotometrically and fluorometry was used to determine the plasma thiobarbituric acid reactive substances (TBARS) and serum advanced glycation end products (AGEs). RESULTS: GSH levels in diabetic subjects without (4.8+/- 0.15 mumol/g Hb) and with microangiopathy (5.2+/- 0.14 micromol/g Hb) were significantly lower (p < 0.001) compared to control subjects (6.3 +/- 0.14 mumol/g Hb). Erythrocyte Na(+)/K(+) ATPase activity was significantly reduced (p < 0.001) in diabetes subjects with (272 +/- 7 nmol Pi/mg protein/h) and without microangiopathy (304 +/- 8) compared to control (374 +/- 6) subjects. TBARS were significantly higher (p < 0.001) in diabetes subjects with (10.65 +/- 0.81 nM/ml) and without microangiopathy (9.90 +/- 0.5 nM/ml) compared to control subjects (5.18 +/- 0.18 nM/ml). Advanced glycation end product levels were also significantly (p < 0.001) elevated in diabetic subjects with microangiopathy (8.2+/- 1.8 AU) when compared to diabetes subjects without microangiopathy (7.0 +/- 2.0 AU) and control subjects (4.6 +/- 1.9 AU). On multivariate regression analysis, GSH levels showed a positive association with the Na(+)/K(+) ATPase activity and negative association with TBARS and AGE levels. CONCLUSION: Hypoglutathionemia and increased oxidative stress appears to be early biochemical aberrations in diabetes, and through protein alterations, oxidative stress and redox modifications may contribute to pathogenesis of diabetic microangiopathy.
OBJECTIVE: Although recent studies link altered cellular redox state to protein dysfunction in various disease-states, such associations are least studied in clinical diabetes. Therefore, this study assessed the levels of reduced glutathione (GSH) and Na(+)/K(+) ATPase activities in type 2 diabeticpatients with and without microangiopathy. METHODS: The study group comprised of a total of 160 subjects, which included non-diabetic healthy controls (n = 40) and type 2 diabeticpatients without (n = 60) and with microangiopathy (n = 60), defined as presence of retinopathy with or without nephropathy. Erythrocyte Na(+)/K(+) ATPase activity and GSH levels were estimated spectrophotometrically and fluorometry was used to determine the plasma thiobarbituric acid reactive substances (TBARS) and serum advanced glycation end products (AGEs). RESULTS:GSH levels in diabetic subjects without (4.8+/- 0.15 mumol/g Hb) and with microangiopathy (5.2+/- 0.14 micromol/g Hb) were significantly lower (p < 0.001) compared to control subjects (6.3 +/- 0.14 mumol/g Hb). Erythrocyte Na(+)/K(+) ATPase activity was significantly reduced (p < 0.001) in diabetes subjects with (272 +/- 7 nmol Pi/mg protein/h) and without microangiopathy (304 +/- 8) compared to control (374 +/- 6) subjects. TBARS were significantly higher (p < 0.001) in diabetes subjects with (10.65 +/- 0.81 nM/ml) and without microangiopathy (9.90 +/- 0.5 nM/ml) compared to control subjects (5.18 +/- 0.18 nM/ml). Advanced glycation end product levels were also significantly (p < 0.001) elevated in diabetic subjects with microangiopathy (8.2+/- 1.8 AU) when compared to diabetes subjects without microangiopathy (7.0 +/- 2.0 AU) and control subjects (4.6 +/- 1.9 AU). On multivariate regression analysis, GSH levels showed a positive association with the Na(+)/K(+) ATPase activity and negative association with TBARS and AGE levels. CONCLUSION: Hypoglutathionemia and increased oxidative stress appears to be early biochemical aberrations in diabetes, and through protein alterations, oxidative stress and redox modifications may contribute to pathogenesis of diabetic microangiopathy.
Authors: Andrew M Jenner; J Emilio Ruiz; Christina Dunster; Barry Halliwell; Giovanni E Mann; Richard C M Siow Journal: Arterioscler Thromb Vasc Biol Date: 2002-04-01 Impact factor: 8.311
Authors: Joshua A Beckman; Allison B Goldfine; Jane A Leopold; Mark A Creager Journal: Am J Physiol Heart Circ Physiol Date: 2016-10-07 Impact factor: 4.733
Authors: Mustapha Umar Imam; Nur Hanisah Azmi; Muhammad Iqbal Bhanger; Norsharina Ismail; Maznah Ismail Journal: Evid Based Complement Alternat Med Date: 2012-12-06 Impact factor: 2.629
Authors: Zhe-Wei Fei; Vernon R Young; Xiao-Ming Lu; Andrew B Rhodes; Ronald G Tompkins; Alan J Fischman; Yong-Ming Yu Journal: Burns Trauma Date: 2013-09-18